DOVA PHARMACEUTI. DL-,001 WKN: A2DT59 ISIN: US25985T1025 Kürzel: 0AV Forum: Aktien Thema: Hauptdiskussion

Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) announced it will be acquired by Swedish Orphan Biovitrum AB. Dova stockholders will be offered an upfront payment for $27.50 per share in cash, along with one non-tradeable Contingent Value Right (CVR) that entitles them to an additional $1.50 per share in cash upon regulatory approval of Doptelet for the treatment of chemotherapy-induced thrombocytopenia (CIT), representing a total potential consideration of up to $915m. Shares closed up 38% to $27.95.

DOVA PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR DOPTELET® (AVATROMBOPAG) FOR TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) http://investors.dova.com/news-releases/news-release-details/dova-pharmaceuticals-announces-fda-approval-supplemental-new

As of March 31, 2019, Dova had $92.7 million in cash and equivalents compared to $104.6 million as of December 31, 2018.  Additionally, on May 6, 2019, Dova entered into an amended and restated loan agreement with Silicon Valley Bank that extends the interest only period of the existing $20 million loan facility by 12 months and provides additional potential borrowings of $30 million upon achieving certain clinical and revenue milestones. https://finance.yahoo.com/news/dova-pharmaceuticals-reports-first-quarter-110000179.html?.tsrc=rss

sNDA under review by the U.S. FDA for DOPTELET for the treatment of chronic immune thrombocytopenia (ITP); PDUFA date June 30, 2019

Dova Pharmaceuticals Announces Four Presentations on Avatrombopag in Patients with Chronic Immune Thrombocytopenia at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress https://finance.yahoo.com/news/dova-pharmaceuticals-announces-four-presentations-120000016.html?.tsrc=rss

Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET® (avatrombopag) for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease https://finance.yahoo.com/news/dova-pharmaceuticals-announces-european-union-120000914.html?.tsrc=rss

Erster!!!👍😅